Investment
Features
FeesSafety
Academy
More
Pluang+

Boot Barn's price target raised to $224, signaling 85% growth potential amid margin expansion plans.

Analyst Insights
29 Sep 2026
Alex Lavoie
View Source
Bullish
Boot Barn's price target raised to $224, signaling 85% growth potential amid margin expansion plans.

Analyst firm Craig-Hallum adjusted Boot Barn Holdings' price target to $224, an 84.91% increase from its recent stock price of $121.14, reflecting strong growth potential. The company aims to expand merchandise margins by 60 basis points in fiscal 2027 through supply-chain efficiencies, better sourcing, and volume discounts. Boot Barn, a lifestyle retailer specializing in Western and work-related apparel and footwear, is also seen as undervalued by 29.7% according to GuruFocus, which gives it a strong performance score of 91. However, insiders have sold $1.7 million in shares over the past year with no insider buying recorded.

Boot Barn's recent price target adjustment provides context for consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Sep 30, 2026 00:02 WIB: out of 112 priced Consumer Cyclical-sector US stocks tradable on Pluang, 33 rose and 78 fell today. Notable movers include Li Auto Inc (LI) at USD 11.12 with a 1-day change of -5.00% and Pluang order activity of 85% Sell / 15% Buy, DraftKings Inc (DKNG) at USD 20.18 with a 1-day change of -4.63%, and Carvana Co (CVNA) at USD 63.22 with a 1-day change of +4.50% and Pluang order activity of 0% Sell / 100% Buy. Typical hold times on Pluang range from 28 to 101 days among these stocks.

More News

Precision Optics posts 42% revenue growth and beats Q4 EPS estimates with improved margins.

Precision Optics posts 42% revenue growth and beats Q4 EPS estimates with improved margins.

Precision Optics Corporation reported a strong Q4 with record revenue of $8.8 million, a 42% increase year-over-year, surpassing analyst estimates of $7.1 million. The company also beat EPS expectations, posting -$0.01 versus the predicted -$0.06, si...

Company Fundamentals
Bullish
1 hour ago
Inventiva reports H1 2026 loss improvement, NATiV3 trial ends, topline results due Q4 2026

Inventiva reports H1 2026 loss improvement, NATiV3 trial ends, topline results due Q4 2026

Inventiva announced improved financial results for the first half of 2026, reducing its net loss to €69.5 million from €175.9 million the previous year. The company completed the final patient visit in its Phase 3 NATiV3 trial for MASH, with topline ...

Company Fundamentals
Neutral
2 hours ago
Jabil readies Q4 earnings amid strong AI growth and automotive sector concerns

Jabil readies Q4 earnings amid strong AI growth and automotive sector concerns

Jabil is set to report its Q4 earnings on September 30, 2026, with analysts expecting earnings per share around $4.07 and revenue near $9.71 billion, marking a 16.5% revenue increase year-over-year. The company is benefiting from robust growth in AI ...

Company Fundamentals
Bullish
2 hours ago
Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...

Analyst Insights
Bullish
2 hours ago
Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App